LSL Pharma Group Inc (TSE:LSL) has released an update.
LSL Pharma Group Inc. has initiated a private placement financing scheme to raise $3 million in cash and convert $1.5 million of debt into equity. The company plans to use the proceeds to enhance production capacity and reinforce working capital. Investors will receive units priced at $0.40, each comprising a common share and a purchase warrant, with the warrants allowing the purchase of additional shares at $0.70 within a 24-month period.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.
